See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367644_2024_Emergent_Biosolutions_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 183.08771929824562, 'aggregate_val': 1049300000, 'exp_sum': 5700000, 'exp_to_value': {'remainder_Revenues': 5700000}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 1043600000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.313475997686524, 'aggregate_val': 1200000000, 'exp_sum': 518700000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 308000000, 'ResearchAndDevelopmentExpense': 70700000, 'remainder_Expenses': 140000000}} |
Graph
Absolute values for 0001367644, Emergent Biosolutions Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 679,500,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 566,600,000 |
| 2 | PropertyPlantAndEquipmentNet | 382,800,000 |
| 3 | remainder_Assets | 194,300,000 |
| 4 | LiabilitiesCurrent | 651,300,000 |
| 5 | LiabilitiesNoncurrent | 475,400,000 |
| 6 | remainder_Liabilities | 47,200,000 |
| 7 | CostOfGoodsAndServicesSold | 702,140,069 |
| 8 | SellingGeneralAndAdministrativeExpense | 376,195,333 |
| 9 | ResearchAndDevelopmentExpense | 100,708,883 |
| 10 | remainder_Expenses | 314,821,522 |
| 11 | remainder_Revenues | 1,028,335,759 |
| 12 | remainder_NetIncome | -13,015,249 |
| 13 | remainder_ComprehensiveNetIncome | -2,773,475 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,823,200,000 |
| 1 | Liabilities | 1,173,900,000 |
| 2 | Expenses | 1,493,865,807 |
| 3 | Revenues | 1,028,335,759 |
| 4 | StockholdersEquity | 649,300,000 |
| 5 | NetIncome | -478,545,297 |
| 6 | ComprehensiveNetIncome | -479,932,034 |
| 7 | BaseVar | 2,767,545,145 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.624 |
| 9 | EconomicCapitalRatio | 1.99 |